Torrent Pharmaceuticals Limited - Company Snapshot & SWOT Analysis
Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical company in India by FY 2014 sales. The company is engaged in manufacturing and marketing of branded and unbranded generic formulations. Currently, the company consumes most of the APIs manufactured in its facility, and only a fraction is sold to the external consumers. Also, the company is engaged in contract manufacturing of formulations for pharmaceutical majors. For the last fifteen years, Torrent Pharmaceuticals has been manufacturing Insulin for Novo Nordisk Indian operations.
During the period of 2013-2018, the company increased its revenue from INR 32.11 bn to INR 60.2 bn. During the same period, the company registered the annual growth rate of 13.39%
In 2014 the revenue for India market for Torrent pharma was INR 11.61 bn which increased to INR 23.51 bn in 2018, registering an annual growth rate of 19.29%.
Scope of the Torrent Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report
During the period of 2013-2018, the company increased its revenue from INR 32.11 bn to INR 60.2 bn. During the same period, the company registered the annual growth rate of 13.39%
In 2014 the revenue for India market for Torrent pharma was INR 11.61 bn which increased to INR 23.51 bn in 2018, registering an annual growth rate of 19.29%.
Scope of the Torrent Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report
- This report provides detailed information about Torrent Pharmaceuticals Limited including value chain analysis, financial performance, business strategy, and SWOT analysis.
- The report identifies the growth drivers and inhibitors for global pharmaceutical market.
- This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY
Scope of the Torrent Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Torrent Pharmaceuticals Limited
3.1.1 Company Profile
3.1.2 Torrent Pharmaceuticals in Pharma Manufacturing Value Chain
3.1.3 Torrent Pharmaceuticals: Financial Performance
3.1.4 Torrent Pharmaceuticals: Business Strategy
3.1.5 SWOT Analysis of Torrent Pharmaceuticals Limited
Strengths
Weaknesses
Opportunities
Threats
3.1.6 Key Customers of Torrent Pharmaceuticals
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
Scope of the Torrent Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Torrent Pharmaceuticals Limited
3.1.1 Company Profile
3.1.2 Torrent Pharmaceuticals in Pharma Manufacturing Value Chain
3.1.3 Torrent Pharmaceuticals: Financial Performance
3.1.4 Torrent Pharmaceuticals: Business Strategy
3.1.5 SWOT Analysis of Torrent Pharmaceuticals Limited
Strengths
Weaknesses
Opportunities
Threats
3.1.6 Key Customers of Torrent Pharmaceuticals
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
LIST OF EXHIBITS
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Torrent Pharmaceuticals Limited
Exhibit 3.2 Contact Information of Torrent Pharmaceuticals Limited
Exhibit 3.3 Torrent Pharmaceuticals Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Torrent Pharmaceuticals Limited Revenue 2013-2018 (in INR billion)
Exhibit 3.5 Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2014-18 (in %)
Exhibit 3.6 Torrent Pharma Ltd, India Revenue (in INR bn)
Exhibit 3.7 Year wise Torrent Pharma Ltd. India Revenue Growth (in %)
Exhibit 3.8 Torrent Pharma Ltd. US sales Revenue (in INR bn)
Exhibit 3.9 Year wise Torrent Pharma Ltd. US sales Revenue Growth (in %)
Exhibit 3.10 Torrent Pharma Ltd. Germany Revenue (in INR bn)
Exhibit 3.11 Year wise Torrent Pharma Ltd. Germany Revenue Growth (in %)
Exhibit 3.12 Torrent Pharma Ltd. Brazil Revenue (in INR bn)
Exhibit 3.13 Year wise Torrent Pharma Ltd. Brazil Revenue Growth (in %)
Exhibit 3.14 Torrent Pharma Ltd. Others Revenue (in INR bn)
Exhibit 3.15 Year wise Torrent Pharma Ltd. Others Revenue Growth (in %)
Exhibit 3.16 Source Wise Revenue Share of Torrent Parma Ltd, (in %)
Exhibit 3.17 Source wise Revenue CAGR Growth Forecast for Torrent Pharma Ltd. 2019-23 (in %)
Exhibit 3.18 Forecast of Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.19 Forecast of India Market Revenue for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.20 Forecast of US Market Revenue for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.21 Forecast of Germany for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.22 Forecast of Brazil for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.23 Forecast of Others for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.24 Key Products of Torrent Pharmaceuticals Limited
Exhibit 3.25 SWOT Analysis of Torrent Pharmaceuticals Limited
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Torrent Pharmaceuticals Limited
Exhibit 3.2 Contact Information of Torrent Pharmaceuticals Limited
Exhibit 3.3 Torrent Pharmaceuticals Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Torrent Pharmaceuticals Limited Revenue 2013-2018 (in INR billion)
Exhibit 3.5 Year-wise Torrent Pharmaceuticals Limited Revenue Growth 2014-18 (in %)
Exhibit 3.6 Torrent Pharma Ltd, India Revenue (in INR bn)
Exhibit 3.7 Year wise Torrent Pharma Ltd. India Revenue Growth (in %)
Exhibit 3.8 Torrent Pharma Ltd. US sales Revenue (in INR bn)
Exhibit 3.9 Year wise Torrent Pharma Ltd. US sales Revenue Growth (in %)
Exhibit 3.10 Torrent Pharma Ltd. Germany Revenue (in INR bn)
Exhibit 3.11 Year wise Torrent Pharma Ltd. Germany Revenue Growth (in %)
Exhibit 3.12 Torrent Pharma Ltd. Brazil Revenue (in INR bn)
Exhibit 3.13 Year wise Torrent Pharma Ltd. Brazil Revenue Growth (in %)
Exhibit 3.14 Torrent Pharma Ltd. Others Revenue (in INR bn)
Exhibit 3.15 Year wise Torrent Pharma Ltd. Others Revenue Growth (in %)
Exhibit 3.16 Source Wise Revenue Share of Torrent Parma Ltd, (in %)
Exhibit 3.17 Source wise Revenue CAGR Growth Forecast for Torrent Pharma Ltd. 2019-23 (in %)
Exhibit 3.18 Forecast of Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.19 Forecast of India Market Revenue for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.20 Forecast of US Market Revenue for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.21 Forecast of Germany for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.22 Forecast of Brazil for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.23 Forecast of Others for Torrent Pharma Ltd. 2019-23 (in INR bn)
Exhibit 3.24 Key Products of Torrent Pharmaceuticals Limited
Exhibit 3.25 SWOT Analysis of Torrent Pharmaceuticals Limited
